AstraZeneca Seeks Approval for COVID-19 Drug

Don Ma
By Don Ma
October 5, 2021NTD Businessshare

British drugmaker AstraZeneca wants U.S. regulators to authorize its new antibody drug for emergency use. The drug could be an alternative to vaccination.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.